MANJUL DERASARI: Open Payments
NPI 1912969775 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 17 payments from 9 companies in 2025. Trend: 2023 $407 · 2024 $169 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $71 |
| Medtronic, Inc. | 3 | $61 |
| PROTEGA PHARMACEUTIALS INC | 3 | $56 |
| SI-BONE, INC. | 2 | $49 |
| Abbott Laboratories | 2 | $35 |
| Averitas Pharma Inc. | 1 | $22 |
| Coastal Medical Technologies LLC | 1 | $22 |
| Globus Medical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
Products named: ROXYBOND, WaveWriter Alpha Prime 16, KYPHON EXPRESS II KYPHOPAK TRAY, QUTENZA, Senza, PROCLAIM, BOTOX, INCEPTIV.
Industry payments across FL — which companies pay providers there.
